Results 21 to 30 of about 507,262 (350)
Pharmacological and clinical application of heparin progress: An essential drug for modern medicine.
Heparin is the earliest and most widely used anticoagulant and antithrombotic drug that is still used in a variety of clinical indications. Since it was discovered in 1916, after more than a century of repeated exploration, heparin has not been replaced ...
Min Qiu +9 more
semanticscholar +1 more source
Physical mixtures of cationic polymers and heparin have been developed to overcome the limitations of unfractionated heparin. In this study, we found that heparin associates with natural polyamines in water, resulting in the generation of a poly-ion ...
Daichi Ito +8 more
doaj +1 more source
The dependence of development and homeostasis in animals on the interaction of hundreds of extracellular regulatory proteins with the peri- and extracellular glycosaminoglycan heparan sulfate (HS) is exploited by many microbial pathogens as a means of ...
Courtney J. Mycroft-West +24 more
semanticscholar +1 more source
Heparin-Assisted Amyloidogenesis Uncovered through Molecular Dynamics Simulations [PDF]
Glycosaminoglycans (GAGs), in particular, heparan sulfate and heparin, are found colocalized with Aβ amyloid. They have been shown to enhance fibril formation, suggesting a possible pathological connection.
Alamzeb Khan (12441416) +11 more
core +1 more source
Many pathogens take advantage of the dependence of the host on the interaction of hundreds of extracellular proteins with the glycosaminoglycans heparan sulphate to regulate homeostasis and use heparan sulphate as a means to adhere and gain access to ...
Courtney J. Mycroft-West +11 more
semanticscholar +1 more source
Heparin modification of a biomimetic bone matrix modulates osteogenic and angiogenic cell response in vitro [PDF]
In this study, the effect of heparin-modified collagen type I/hydroxyapatite (HA) nanocomposites on key processes of bone regeneration – osteogenesis and angiogenesis – was characterised in vitro.
M Quade +9 more
doaj +1 more source
Heparin as a therapy for COVID-19: current evidence and future possibilities
Coronavirus disease 2019 (COVID-19), the clinical syndrome associated with infection by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has impacted nearly every country in the world.
J. Hippensteel +4 more
semanticscholar +1 more source
Heparin release kinetics in blood gas syringes [PDF]
Background: In view of the urgency of results quality and operational availability of point of care analyzers is of high importance in ICUs and operational theatres. Methods: We investigated the influence of time on release and total amount of Heparin in
Bechmann, Volker +2 more
core +1 more source
Serologic characterization of anti-protamine/heparin and anti-PF4/heparin antibodies
: Anti-protamine (PRT)/heparin antibodies are a newly described class of heparin-dependent antibodies occurring in patients exposed to PRT and heparin during cardiac surgery.
Grace M. Lee +6 more
doaj +1 more source

